Cambium Bio Limited
CMB
Classement en actions
#32452
Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on... Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides lead product candidate is Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Prix de l'action
$0.31613178
Dernière synchronisation: 2026-10-21
Capitalisation boursière
$9.30M
Changement (1 jour)
-0.39%
Changement (1 an)
5,893.70%
Pays
AU
Échange Cambium Bio Limited (CMB)
Catégorie
Healthcare
Historique du prix de l'action pour Cambium Bio Limited (CMB)
Prix de clôture le plus élevé : $0.01 le 2024-05-01
Prix de clôture le plus bas : $0.25 le 2013-09-01
Prix de clôture le plus bas : $0.25 le 2013-09-01
Historique du prix de l'action de Cambium Bio Limited de 2013 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2024 | 119.50% |
| 2023 | -92.08% |
| 2022 | -41.49% |
| 2021 | -42.78% |
| 2020 | 56.83% |
| 2019 | -53.42% |
| 2018 | 31.72% |
| 2017 | -21.51% |
| 2016 | 74.18% |
| 2015 | -41.39% |
| 2014 | -67.54% |
| 2013 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $536.13 | 25.72% |
US
|
|
| $200.12 | 645.31% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $880.01 | 8.09% |
NL
|
